CBIO vs GIS · rev $1.0M vs P/E 8.2, rev $4.61B
Crescent Biopharma, Inc. (CBIO) versus General Mills Inc (GIS) — a side-by-side from cached financials, not a winner call.
Crescent Biopharma, Inc. (CBIO) is a biotechnology company listed on NASDAQ.
General Mills Inc (GIS) is a packaged foods company listed on NYSE.
Latest reported CBIO revenue for 2026-06-30 was $1.0M. Net income was -$48.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. CBIO currently screens at market cap $491.3M.
Latest reported GIS revenue for 2026-05-31 was $4.61B. Net income was -$2.01B. Revenue was up 1.2% from 2025-05-25 to 2026-05-31. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
CBIO currently screens at market cap $491.3M. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
Not investment advice. Open the CBIO and GIS stock pages for the full models.
Not investment advice.